Investigating the FIB-4 index and PET/CT metabolic parameters for the differentiation status of hepatocellular carcinoma
- 20 March 2026
- journal article
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (suppl2) , 167-171
Abstract
Aim The FIB-4 index is a widely used noninvasive marker of hepatic fibrosis and has prognostic value in hepatocellular carcinoma (HCC). However, its association with tumor differentiation remains unclear. This study aimed to investigate the relationship between the fibrosis-4 (FIB-4) index and histological differentiation of HCC using 18F- fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters. Methods This retrospective, single-center study included 110 patients with newly diagnosed, histologically confirmed HCC who underwent 18F-FDG PET/CT between 2017 and 2024. Patients with moderately differentiated or unclassified tumors, prior liver-directed therapies, recurrent HCC, or other malignancies were excluded. Tumors were categorized as well-differentiated or poorly-differentiated. PET/CT-derived metabolic parameters were analyzed. The FIB-4 index was calculated at the time of imaging. Group comparisons, correlation analyses, and receiver operating characteristic (ROC) curve analyses were performed to evaluate associations among FIB-4, metabolic parameters, and tumor differentiation. Results The median FIB-4 index did not differ significantly between well- and poorly differentiated HCC groups (4.2 vs. 4.5, p = 0.765). No significant correlation was observed between the FIB-4 index and PET metabolic parameters (all p > 0.05). In contrast, poorly-differentiated HCCs showed significantly higher metabolic activity, with markedly elevated SUVmax, SUVmean, SUVpeak, tumor-to-liver and tumor-to-blood ratios (all p < 0.001). ROC analysis showed that SUVmax had the highest diagnostic performance for predicting poor differentiation (AUC = 0.981), whereas the FIB-4 index had poor discriminative ability (AUC = 0.517). Conclusion The FIB-4 index does not reflect histological differentiation in HCC and has limited utility for tumor grading. 18F-FDG PET/CT metabolic parameters provide superior discrimination of tumor differentiation, although overlap between grades underscores the need for a multimodal diagnostic approach.This publication has 23 references indexed in Scilit:
- The potential of 18F-FDG PET/CT metabolic parameter-based nomogram in predicting the microvascular invasion of hepatocellular carcinoma before liver transplantationAbdominal Radiology, 2024
- Exploring the efficacy of 18F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiationAbdominal Radiology, 2023
- Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantationAbdominal Radiology, 2021
- Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinomaAnnals of Hepatology, 2019
- Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology, 2015
- FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver functionJournal of Cancer Research and Clinical Oncology, 2015
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2014
- PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004